Biotech Stock Comparison

Compare the best Biotech stocks, get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Compare up to 7 stocks

Comparison Results

Name
Price
Price Change
Price Target Upside
Market Cap
PE Ratio
Yearly Gain
Analyst Consensus
Follow
GILDGilead Sciences
$69.07
0.54 (0.79%)
$78.58
(13.77% Upside)
86.63B
285.50
-4.42%
10Buy
6Hold
0Sell
0
Moderate Buy
AMGNAmgen
$252.38
1 (0.4%)
$244.00
(-3.32% Downside)
145.01B
20.80
10.85%
8Buy
9Hold
2Sell
0
Moderate Buy
VRTXVertex Pharmaceuticals
$216.35
-0.74 (-0.34%)
$273.08
(26.22% Upside)
56.01B
20.70
-23.59%
11Buy
4Hold
0Sell
0
Moderate Buy
BIIBBiogen
$280.40
0.19 (0.07%)
$312.69
(11.52% Upside)
42.22B
14.50
-11.30%
9Buy
9Hold
2Sell
0
Moderate Buy
ILMNIllumina
$379.48
-1.55 (-0.41%)
$426.00
(12.26% Upside)
55.40B
89.00
10.72%
4Buy
4Hold
2Sell
0
Hold

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Biotech Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Biotech Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
AMGNAmgen Inc
Buy
Assigned
VRTXVertex Pharmaceuticals Inc.
Buy
Reiterated
GILDGilead Sciences
Buy
Reiterated
BIIBBiogen Inc.
Hold
Reiterated
ILMNIllumina
Buy
Reiterated
GILDGilead Sciences
Buy
Reiterated
GILDGilead Sciences
Buy
Reiterated
GILDGilead Sciences
Buy
Reiterated
AMGNAmgen Inc
Hold
Reiterated
VRTXVertex Pharmaceuticals Inc.
Hold
Assigned

Most Recent Earnings of Biotech Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
GILDGilead Sciences
Apr 29, 2021
2021 (Q1)
2.08/1.37
1.221
12.20% (+0.15)
AMGNAmgen
Apr 27, 2021
2021 (Q1)
4.05/2.83
3.072
-7.78% (-0.24)
VRTXVertex Pharmaceuticals
Apr 29, 2021
2021 (Q1)
2.70/2.49
2.287
9.05% (+0.21)
BIIBBiogen
Apr 22, 2021
2021 (Q1)
4.98/2.69
8.083
-66.68% (-5.39)
ILMNIllumina
Apr 27, 2021
2021 (Q1)
1.39/1.00
1.169
-14.46% (-0.17)

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?
These Biotech stocks currently have a "Strong Buy" analyst rating consensus:
None of the selected stocks have a “Strong Buy” analyst rating consensus.
Are Biotech stocks overpriced?
Gilead Sciences's stock price is currently $69.07, and its average 12-month price target is $78.58.
Amgen's stock price is currently $252.38, and its average 12-month price target is $244.00.
Vertex Pharmaceuticals's stock price is currently $216.35, and its average 12-month price target is $273.08.
Biogen's stock price is currently $280.40, and its average 12-month price target is $312.69.
Illumina's stock price is currently $379.48, and its average 12-month price target is $426.00.
Which Biotech stocks pay dividends?
Gilead Sciences currently pays a dividend of $0.71 which represents an annual dividend yield of 4.14%. Gilead Sciences's next Ex-dividend date is June 14, 2021 and its next payout date is June 29, 2021.
Amgen does not currently pay dividends.
Vertex Pharmaceuticals does not currently pay dividends.
Biogen does not currently pay dividends.
Illumina does not currently pay dividends.